Skip to main content

Table 3 Characteristics of acute kidney injury adverse medication warnings generated in the SunRise Clinical Manager electronic medication record from the silent alert phase on 14 medical and surgical hospital units in the Calgary Zone over a 30-day observation period

From: Development and initial implementation of electronic clinical decision supports for recognition and management of hospital-acquired acute kidney injury

Alert Frequency

Number (%)

Total AKI adverse medication warnings

21 (100.0%)

AKI stage at time of adverse medication warning

 Stage 1 AKI alerts

15 (71.4)

 Stage 2 AKI alerts

2 (9.6)

 Stage 3 AKI alerts

4 (19.0)

Medication orders prompting AKI adverse medication warning

 Diuretics

11 (52.4)

 Antibiotics

4 (19.0)

 ACE-I/ARB

3 (14.23)

 NSAID

3 (14.3)

Medical unit

10 (47.6)

Surgical unit

11 (52.4)

  1. AKI acute kidney injury, ACE-I angiotensin converting enzyme inhibitors, ARB angiotensin receptor blockers, NSAID non-steroidal anti-inflammatory drugs